Final Recommendation Statement: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication - US Preventive Services Task Force

Final Recommendation Statement: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication - US Preventive Services Task Force

Final Recommendation Statement:

Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

Final Recommendation Statement: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum The U.S. Preventive Services Task Force released today a final recommendation statement on ocular prophylaxis for gonococcal ophthalmia neonatorum. The Task Force found that all newborns should receive antibiotic ointment to prevent a serious eye infection. To view the recommendation and the evidence on which it is based, please go here. The final recommendation statement can also be found in the January 29, 2019 online issue of JAMA.

The Final Recommendation Statement Is Available

FINAL RECOMMENDATION SUMMARY See the full statement

Population Recommendation Grade Newborns The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. A

WHY THIS MATTERS

"The Task Force continues to recommend that all newborns are given antibiotic ointment to prevent gonococcal ophthalmia neonatorum,” says Task Force member and pediatrician Michael Silverstein, M.D., M.P.H. “The medicine is safe and highly effective at preventing this serious eye infection and its devastating consequences, including blindness.”

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review  Final Recommendation / Evidence Summary